This Week in Psychedelics - 3.18.22

Cannabis

• Israeli Town of Tira Founds First Medical Cannabis Cafe (High Times)

• Kentucky House Passes Medical Marijuana Legalization Bill (Marijuana Moment)

• Delaware House Shoots Down Recreational Legalization Bill (High Times)

• New VA Veteran Suicide Program Won’t Allow Cannabis as Treatment (High Times)

• Mike Tyson's cannabis brand is making ear-shaped weed gummies (NBC News)

• Marijuana Legalization Hasn’t Led To More Youth Use, Report From Alcohol And Tobacco Industry-Backed Group Says (Marijuana Moment)

• Oklahoma Thieves Impersonate Cops and Raid Several Pot Farms (High Times)

• Alabama Bill Would Force Women Who Want Medical Marijuana To Show Negative Pregnancy Tests (Marijuana Moment)

• Montana Supreme Court OKs Temporary Rules For Cannabis Expungement (High Times)

• New Orleans City Council Urges End To Marijuana Testing For Government Employees (Marijuana Moment)

• Georgia Lawmakers Consider Separate Medical Cannabis Production Bills (High Times)

• Some Mississippi Cities Move To Ban Medical Marijuana Businesses (Marijuana Moment)

• European Commission Sets Standards for Hemp Food (High Times)

• Jones Soda Company Announces Cannabis-Infused Product Line (High Times)

LSD

• Montreal researchers find that, like Prozac, LSD may be useful for anxiety treatment (CTV News)

• Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety (BioSpace)

Magic Mushrooms

• California Activists Drop 2022 Psilocybin Legalization Ballot Initiative After Falling Short Of Signature Requirement (Marijuana Moment)

• Little evidence on how psilocybin therapy interacts with existing psychiatric treatments, review finds (OHSU News)

• California Psychedelics Investors Are Closely Monitoring Oregon’s Psilocybin Market (Willamette Week)

• Washington State Legislature Approves $200,000 In Psilocybin Research Funding In Budget (Marijuana Moment)

• Novamind announces phase 2 trial examining psilocybin for MDD (Healio)

• Psilocybin Is The Most Studied Psychedelic (Green Market Report)

MDMA

• MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests (PsyPost)

• Dose-ranging study provides insight into MDMA’s effects on memory, addiction, and depression (PsyPost)

Ayahuasca

• Federal judge dismisses ayahuasca church’s request for overturn of DEA decision (WFTV)

• Study will investigate ayahuasca to overcome prolonged grief (Ruetir)

• Controversy Over Injustice Against Ayahuasca Traditional Knowledge Rebounds (Chacruna)

Ketamine

• A Ketamine Clinic Treads the Line Between Health Care and a ‘Spa Day for Your Brain’ (The New York Times)

Miscellaneous

• Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy (Marijuana Moment)

• Students Launch Bid to Decriminalize All Drugs in Ann Arbor, Michigan (Filter)

• New Research Explores Whether Therapeutic Psychedelics Can Fix ‘Biophobia’ (Forbes)

• Keywords from hallucinogenic experiences can help find parts of the brain affected by drugs (The Verge)

• Feds Reveal Which Industries Drug Test Workers The Most And Least In New Report (Marijuana Moment)

• MDMA use drops due to COVID lockdowns, other drugs rise -EU report (Reuters)

• What do psychedelic drugs do to our brains? AI could help us find out (MIT Technology Review)

• How Can We Apply Harm Reduction to HPPD? (Psychedelics Today)

• Colorado Activists Pick One Of Several Psychedelics Reform Initiatives To Pursue For November Ballot (Marijuana Moment)

• London should pilot drug checking and consumption rooms, says report (London Evening Standard)

• Current Psychedelic Therapies Use Flawed Models of the Mind – It’s Time for Relational Therapy (Healing Maps)

• Mind Cure Health Halts All Psychedelic Business Activity (Psychedelic Spotlight)

• Are drug wars protection rackets? (Drug WarRant)

• Microdosing Is On The Rise But Is It Healthy? (The Dales Report)

• Terence McKenna’s Anarchic Psychedelic Religion (JSTOR Daily)

• Coming of Age in the Psychedelic Sixties (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.4.22

Cannabis

• Mississippi governor signs law allowing medical marijuana (Leafly)

• The NFL is throwing $1 million into cannabinoid research (Leafly)

• House Officially Approves Marijuana Banking Amendment To Large-Scale Bill Set For Final Passage Friday (Marijuana Moment)

• Delta-8 Debate: The 2018 Farm Bill gave rise to an unlikely intoxicant (Marijuana Business Daily)

• House Advances SAFE Banking Act as Part of the America COMPETES Act (NORML)

• Driving Performance and Cannabis Users’ Perception of Safety - Review (Drug Science)

• Minnesota: Patients’ Access to Herbal Cannabis Products Begins March 1 (NORML)

• Claim of Fentanyl-Laced Cannabis Overdoses in Connecticut was False (High Times)

• Cannabis being used to treat symptoms of Long Covid in new landmark trial (Mirror)

• ‘The science about the benefits of cannabis is limited’: Does legalizing marijuana lead to an increase in tobacco use? (MarketWatch)

• Utah Lawmakers Pass Bill To Protect Medical Cannabis Patients (High Times)

• A Cannabis Monopoly Asteroid is Coming (Marijuana Moment)

• Petition Forces Ohio Lawmakers into Action on Cannabis Legalization (High Times)

• Marijuana legalization push increasingly unites unlikely political bedfellows (Marijuana Business Daily)

• 2021: A Year In Review For The Cannabis Industry (Forbes)

• Top Maryland Lawmaker Files Marijuana Legalization Bill In Anticipation Of Ballot Referendum Passing (Marijuana Moment)

• Pennsylvania Issues Mandatory Recall for Hundreds of Cannabis Products (New Cannabis Ventures)

• Wisconsin Governor Vetoes GOP Bill To Increase Marijuana Extraction Penalties (Marijuana Moment)

• Republican Lawmakers in Virginia Have Drafted New Cannabis Legislation (High Times)

• Marijuana Banking Reform Cleared For House Floor (Again) Following Committee Action On Large-Scale Bill (Marijuana Moment)

• Can Cannabinoids Unlock a Better Understanding of Our Bodies and Brains? (Discover Magazine)

• Nearly One In Ten New Missouri Jobs Came From Medical Marijuana Industry In 2021, Trade Group Report Finds (Marijuana Moment)

• Jackson seeks cannabis exemption as part of shock comeback at age 40 (The Sydney Morning Herald)

LSD

• Fish on acid? Microdosing zebrafish with LSD shows its potential benefits for humans (The Conversation)

• What to know about microdosing LSD (Medical News Today)

Magic Mushrooms

• Virginia Psilocybin Decriminalization Bill Defeated In Senate Committee After Top GOP Lawmaker Flips Support (Marijuana Moment)

• Religious Practice Under Oregon Measure 109 (Psychedelics Today)

• Maine Lawmakers Hear Testimonies For and Against Psilocybin Bill (Truffle Report)

• Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use (Marijuana Moment)

• America’s only psychedelic mushroom store is a church in Oakland. We observed the sacrament (Leafly)

• Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws (Marijuana Moment)

• Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity Study of AME-1 (Psilocybin Alpha)

• Health Canada Grants Private Company Approval for Healthcare Professionals to Take Psilocybin, Prove Safety (Truffle Report)

MDMA

• Couple Takes MDMA Right Before Grandfather Dies, Trips in Front of Family (Newsweek)

DMT

• Entheon Biomedical Announces the Approval of DMT Clinical Trial (Psilocybin Alpha)

Ayahuasca

• Yaminawa Women and Ayahuasca: Shamanism, Gender, and History in the Peruvian Amazon (Chacruna)

• Women Who Heal: Musicians in the Urban Ayahuasca Scene (Chacruna)

• Madrinha Rita: Brazilian matriarch of ayahuasca (Chacruna)

5-MeO-DMT

• Inside a 5-MeO-DMT Retreat: Who Should and Shouldn’t Embark on This ‘Hero’s Journey’ (Psychedelic Spotlight)

Peyote

• Mining is Threatening the Peyote Tradition in Mexico (Truffle Report)

Ketamine

• Testimony: Minneapolis police trained to ignore city's civil rights report on ketamine and excited delirium (StarTribune)

• Can Ketamine and A.I. Improve Wellness? (Inc)

• PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus (Psilocybin Alpha)

Miscellaneous

• Who Will Control the Future of Psychedelics in Colorado? (Westword)

• Utah Lawmakers Vote To Study Benefits Of Psychedelics In Treating Mental Health Disorders (Marijuana Moment)

• Psychedelics Decriminalization Ballot Proposal Filed in Michigan (Truffle Report)

• I Read Every Neuroscience Study On Psychedelics Published Since 2017. Here’s What I Learned (Healing Maps)

• Researchers use linguistic analysis to uncover differences between psychedelic drug experiences (PsyPost)

• Psychedelic therapy effective in reducing suicidality, more trials needed (Healio)

• Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes (Psychedelic Science Review)

• One Year on, Oregon Drug Decriminalization Is Boosting Harm Reduction and Housing (Filter)

• Looking Ahead to a Psychedelic 2022 (Psilocybin Alpha)

• The Tortured Double Think of the New Drug Strategy (Transform)

• What Happens When Psychedelic Treatment for PTSD Turns Into a Bad Trip (Slate)

• Are Double-Blind Studies Holding Back Psychedelic Research? (The Dales Report)

• What Research Doesn’t Tell Us About Older Psychedelic Users (Lucid News)

• Jeering Psychedelics: A Critique of Jacques Mabit’s Criticism of Queering Psychedelics (Chacruna)

• Are psychedelics dangerous? - What the research says (Drug Science)

• Psychedelics Without the Trip Could Be 'Healing Magic' for Mental Health (Singularity Hub)

• Clinical study of psychedelic drugs for cancer patients could be a ‘game changer’ (The Salt Lake Tribune)

• Sensible policy on psychedelic drugs is growing more common (The Economist)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.14.22

Cannabis

• Oregon State research shows hemp compounds prevent coronavirus from entering human cells (Oregon State University)

• Polls Funded By Marijuana Prohibitionist Group Show Big Support For Legalization Policies It Lobbies Against (Marijuana Moment)

• Top German Government Official Previews Marijuana Legalization Plan Details (Marijuana Moment)

• First-dose vaccinations quadruple in Quebec ahead of restrictions at liquor and cannabis stores (CTV News)

• Mississippi Senate Votes To Legalize Medical Marijuana, Defying Governor’s Veto Threat (Marijuana Moment)

• Oregon: New Rules Increase the Amount of Cannabis Adults Can Purchase Per Transaction (NORML)

• Ohio Marijuana Activists Turn In More Signatures For Legalization Initiative After Temporary Setback (Marijuana Moment)

• Delaware Lawmakers File New Marijuana Legalization Bill With Key Equity Revisions (Marijuana Moment)

• Kansas lawmaker wants to refer medical marijuana legalization to voters (Marijuana Business Daily)

• Austin Officials Certify Local Marijuana Decriminalization Initiative For May Ballot (Marijuana Moment)

• Wyoming Activists Prepare Cannabis Reform Initiatives (High Times)

• Virginia Lawmakers Divided On Releasing Marijuana Prisoners Following Legalization Taking Effect (Marijuana Moment)

• South Dakota Governor Wants Marijuana Activists To Pay Legal Bill For Her Lawsuit That Blocked Legalization (Marijuana Moment)

• Florida Marijuana Activists Pivot To 2024 For Legalization Ballot Initiative (Marijuana Moment)

Magic Mushrooms

• Global Coalition Launches Push To Reschedule Psilocybin Under International Rules (Marijuana Moment)

• Italian Officials Certify Signatures For National Marijuana And Psilocybin Referendum (Marijuana Moment)

• Rollups: The Emerging Magic Mushroom Monopoly (The American Prospect)

• Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

• Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute (PR Newswire)

MDMA

• MAPS Publishes Open Science Approach to Synthesizing MDMA (Lucid News)

Ayahuasca

• A New Study Attempts To Quantify The Healing Powers Of Ayahuasca (Forbes)

Novel Psychoactive Substances

• Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds (Psilocybin Alpha)

• Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development (Psilocybin Alpha)

Ketamine

• Trial of Ketamine Therapy for Alcohol Use Disorder Reports Positive Findings (Technology Networks)

• Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression (Business Wire)

• Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain (Psilocybin Alpha)

• Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy (Forbes)

• PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS (Psilocybin Alpha)

Miscellaneous

• How Beer and Drugs Empowered an Ancient Andean Empire (Gizmodo)

• These States Could Legalize Marijuana Or Psychedelics In 2022 (Marijuana Moment)

• Virginia Could Decriminalize Psilocybin And Other Psychedelics With Newly Filed Bills (Marijuana Moment)

• Social Media Attacks and Ethical Issues in the Psychedelic Sector — Why can’t we all get on together for the greater good? (Medium)

• Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill (Marijuana Moment)

• ‘Microdosers’ of LSD and magic mushrooms are wiser and more creative (Daily Maverick)

• Promising Psychedelic Therapy Legislation Set to Make Waves in 2022 (Psychedelic Spotlight)

• Vermont Lawmakers File Drug Decriminalization Bill With Hopes Of Promoting Harm Reduction (Marijuana Moment)

• Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines (Mind Medicine Australia)

• University Of Ottawa To Offer Psychedelic Studies Master’s Program Beginning In Fall 2022 (Healing Maps)

• The Connection between Psychedelics and Christianity (The Institute for the Advancement of Psychedelic Christianity)

• Metaphysical Insight: Psychedelics, Noetic Experiences, and Spinoza’s God (Sam Woolfe)

• How to Come Out to Your Kids About Psychedelics (DoubleBlind)

• Psychedelics in Healthcare: The Psychedelic Pharmacists Association (Truffle Report)

• Can Western Medicine Include the Sacred in Psychedelic-Assisted Psychotherapy? (Lucid News)

• How To Vet Your Psychedelic Guide (DoubleBlind)

• Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.31.21

Cannabis

• Germany Moves To Legalize Cannabis, Second Country After Malta In Europe (Forbes)

• New Marijuana Laws Take Effect Across The U.S. With The New Year (Marijuana Moment)

• Cannabis in ’22: Is federal legalization on the horizon? (Profiles in Legalization)

• These European Countries Could Legalize Cannabis In 2022 (Forbes)

• New Mexico County Prepares for Recreational Cannabis (U.S. News and World Report)

• New Hampshire Lawmakers File Multiple Marijuana Legalization Bills Ahead Of 2022 Session (Marijuana Moment)

• Indiana Marijuana Legalization And Regulatory Bills Pre-Filed For 2022 Session (Marijuana Moment)

• 2021 Roundup of Cannabis Reform in Europe (and 2022 Predictions) (High Times)

• Cannabis Company Says Afghanistan Plans Hinge On International Recognition Of Taliban Regime (Marijuana Moment)

• Cannabis Testing Prohibited for Most Philadelphia Job Applicants Starting 2022 (High Times)

• How Decriminalization Impacts Racial Disparities in Cannabis Arrests (Filter)

• New Mexico Releases Final Adult-Use Cannabis Rules (High Times)

• Wisconsin Governor Grants Marijuana And Drug-Related Pardons, Setting State Clemency Record (Marijuana Moment)

• Rochester, New York Mayor-Elect Plans Guaranteed Basic Income From Cannabis Taxes (High Times)

• One-Third Of Programmers Use Marijuana While Working, With Many Touting Creative Benefits, Study Finds (Marijuana Moment)

• Australia Cannabis Legalization Support Has Doubled in Six Years (High Times)

• Mississippi Governor Won’t Sign Medical Cannabis Bill Without Major Changes (High Times)

LSD

• When Trey Parker and Matt Stone went to the Oscars on LSD (Far Out Magazine)

Magic Mushrooms

• New Hampshire Lawmakers File Psilocybin And Broader Drug Decriminalization Bills For 2022 (Marijuana Moment)

• Brain Damage From Alcohol May Be Reversed By Using Magic Mushrooms, Per Study (Healing Maps)

• Depression and Grief Wrecked a Man's Life—Until He Took Magic Mushroom Ingredient (Newsweek)

• COMPASS Patent Challenge Targets Crystallography Errors (Psychedelic Science Review)

MDMA

• Warning over high-dose MDMA circulating in Sydney (9News)

Ayahuasca

• Iowa Church Using Hallucinogen During Services Denied Tax-Exempt Status (Newsweek)

Synthetic Cannabinoids

• Children collapse in school after vaping £10 fake cannabis oil laced with Spice ‘sold on Snapchat’ (The Sun)

Nitrous Oxide

• Business offers to deliver dangerous nitrous oxide nangs to your home (Australian Broadcasting Corporation)

Ketamine

• Ketamine Therapy Is Going Mainstream. Are We Ready? (The New Yorker)

• I Took Ketamine for My Depression. Things Got Pretty Weird. (The New York Times)

Miscellaneous

• Drug testing at festivals becomes legal at New Year (New Zealand Herald)

• Feds Announce Funds For Drug Harm Reduction Studies, Including On Decriminalization And Safe Consumption Sites (Marijuana Moment)

• Looking Back at 2021’s Psychedelics Milestones (Truffle Report)

• National Group Submits Colorado Psychedelics Decriminalization Ballot Measures (High Times)

• Here Are The Biggest Marijuana, Psychedelics And Drug Policy News Stories Of 2021 (Marijuana Moment)

• Highlights from a landmark year in psychedelic science (New Atlas)

• How AI Could Prevent the Development of New Illicit Drugs (Undark)

• It’s Been A Banner Year For MAPS Public Benefit Corporation And The Women Leading It (Forbes)

• 2021: A Year in Review for the Psychedelics Business (Psychedelic Spotlight)

• SXSW Selects Multiple Marijuana And Psychedelics Panels For 2022 Festival (Marijuana Moment)

• The Psychedelic Drugs Market to Be Defined By Exceptional Digitization (Lake Shore Gazette)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 8.6.21

Cannabis

• Louisiana: Marijuana Decriminalization Law Takes Effect (NORML)

• Missouri Probation Officers Are Sending People Back to Prison for Legally Using Medical Cannabis (MERRY JANE)

• Trial to test if cannabis-based mouth spray can treat brain tumours (The Guardian)

• Wyoming Marijuana Decriminalization And Medical Cannabis Initiatives Clear First 2022 Ballot Hurdle (Marijuana Moment)

• Puerto Rico: Law Signed Protecting Medical Cannabis Patients from Employment Discrimination (NORML)

• Arkansas Marijuana Activists Push For Legalization Ballot Initiative In 2022 (Marijuana Moment)

LSD

• How the CIA used LSD to fight communism (Big Think)

Magic Mushrooms

• Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals (Psilocybin Alpha)

• COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner (Psymposia)

• Does This Medieval Fresco Show A Hallucinogenic Mushroom in the Garden of Eden? (Atlas Obscura)

• Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin (Psilocybin Alpha)

DMT

• Enzymes Responsible for DMT Synthesis Coexist in Mammalian Brain Cells (Psychedelic Science Review)

• PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease (Psilocybin Alpha)

Ayahuasca

• Addiction Treatment: Ayahuasca May Help Addicts Stop Abusing Alcohol and Drugs (Gilmore Health News)

Mescaline

• Could Synthetic Mescaline Protect Declining Peyote Populations? (Chacruna)

Novel Psychoactive Substances

• Deadly drug 25B-NBOH sold as powdered LSD in Melbourne, spike in Victorian hospitalisations (News.com.au)

Synthetic Cannabinoids

• Lawsuit Filed Over Massachusetts Prisons’ Use of Faulty Drug Tests (Ganjapreneur)

Ketamine

• With a nudge from AI, ketamine emerges as a potential rare disease treatment (STAT)

• Ketamine May Combat Depression in Teens (Lucid News)

Miscellaneous

• Usona Institute Breaks Ground for Global Center in Psychedelic Science (The Joplin Globe)

• Drug deaths in England and Wales highest since 1993 (BBC)

• The Story of “El Chapo” and Why the Drug War Will Never End (The Nation)

• First-ever research centre for psychedelic drug therapy is opening in Australia (Mixmag)

• Fireside Project Releases App for Psychedelic Peer Support (Psilocybin Alpha)

• Modernization of Sacred Plant Medicine Traditions: At What Cost? (Psychedelics Today)

• The Wonderful and Absurd Adventures of Rosemary Woodruff Leary: Fashion Icon, Fugitive, and Psychedelic Pioneer (Part One) (Chacruna)

• Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research (Mad in America)

• Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK (Psilocybin Alpha)

• Two Years After Oakland’s Psychedelic Decrim, What’s Been the Impact? (Filter)

• Improving Y/Our Relationship with Psychedelics (Maps of the Mind)

• Advancing the Psychedelic Renaissance (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.